For citations:
Levchenko E.V., Moiseenko F.V., Orlov S.V., Imyanitov E.N., Mikhnin A.E., Gelfond M.L., Slugin E.N., Ergnyan S.M., Levchenko N.E., Zhabina A.S., Ulitin A.M., Mamontov O.Yu., Lopushanskaya O.O., Artemeva E.V., Murtazin A.I., Shabinskaya V.I. Assessment of the effectiveness of surgical resections following tyrosine kinase inhibitor therapy in patients with EGFR-mutated stage III–IV lung adenocarcinoma. Siberian journal of oncology. 2023;22(1):5-14. (In Russ.) https://doi.org/10.21294/1814-4861-2023-22-1-5-14